MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale

Former Rune Labs and Glooko executive to lead MindMaze’s next phase of growth, focusing on U.S. market expansion and the delivery of scalable, AI-driven neurorestorative care. GENEVA–(BUSINESS WIRE)–MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics, or the Company), a global leader in brain technology and precision neurotherapeutics, today announced the appointment of Zach Henderson as … [Read more…]

Meiji Seika Pharma Initiates Phase I Clinical Trial in Australia Evaluating ME3241, an Anti-PD-1 Agonist Antibody Discovered Through Collaborative Research With FBRI

TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) announced today that it has initiated a Phase I clinical trial of ME3241 (development code), an anti-PD-1 agonist monoclonal antibody discovered through collaborative research with the Foundation for Biomedical Research and Innovation at Kobe (Headquarters: Kobe, Japan; President: Shuh … [Read more…]

United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine

The pivotal study of Tyvaso® (treprostinil) Inhalation Solution demonstrated a statistically significant preservation of lung function across all subgroups, as measured by absolute forced vital capacity (FVC), and fewer clinical worsening events, compared with placebo over 52 weeks in patients with idiopathic pulmonary fibrosis (IPF) Study authors noted TETON-2 is the first study to show … [Read more…]

Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing

New data shows up to 61% reduction in healthcare costs for children with neurodevelopmental disorders in the 12 months following ExomeDx™ and GenomeDx™ testing, regardless of the test result GAITHERSBURG, Md.–(BUSINESS WIRE)–GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced findings from the Genetic … [Read more…]

HIMSS Survey: 60% of Health Systems Can’t Protect Unmanaged Medical Devices

Leaders rank avoiding clinical downtime as their top microsegmentation priority, yet 40% say fear of disruption blocks adoption SAN JOSE, Calif.–(BUSINESS WIRE)–#HIMSS2026—Elisity, the pioneer in identity-based microsegmentation, today announced the release of The Implementation Paradox: Healthcare Leaders Want Microsegmentation-Level Security Without Disruption, a comprehensive report co-published with Healthcare Information and Management Systems Society (HIMSS) Market … [Read more…]

Codoxo Launches Deepfake Detection to Stop AI-Generated Medical Fraud Before Payment

Tool helps payers identify synthetic or manipulated medical documentation and images earlier, strengthening fraud prevention and protecting provider trust DULUTH, Ga.–(BUSINESS WIRE)–Codoxo, the leading provider of AI and generative AI-powered healthcare payment integrity solutions, today announced the launch of Deepfake Detection, an AI-driven fraud detection tool now being deployed with health plans across the U.S. … [Read more…]

Cairn Surgical Announces FDA De Novo 510(k) Submission for Breast Cancer Locator System

LEBANON, N.H.–(BUSINESS WIRE)–#BCSM—Cairn Surgical, Inc., an innovative medical technology firm striving to make breast cancer surgery more precise, announced today that it has submitted a De Novo 510(k) application to the U.S. Food and Drug Administration (FDA) seeking marketing clearance for its Breast Cancer Locator (BCLTM) System. A medical device can be designated for the … [Read more…]

Haleon Strengthens Commitment to China as Consumers Focus on Better Everyday Health

£65m investment in new oral health manufacturing plant in Shanghai to support growth in the world’s largest gum health market Haleon aiming to extend gum health brand parodontax to 30 Chinese cities by end of 2027 – including its fastest growing cities – reaching aspirational shoppers in-store and online Custom designed taste, foamier sensation and … [Read more…]

Galderma Buys Back Shares Worth CHF 232 Million in the Context of Accelerated Bookbuild Offering

Ad hoc announcement pursuant to Art. 53 LR ZUG, Switzerland–(BUSINESS WIRE)–Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it has agreed to repurchase 1.6 million shares at a price of CHF 143.75 per share for a total consideration of CHF 232 million in the context of the accelerated bookbuild offering (“ABO”) of … [Read more…]

HIMSS 2026: Taiwanese Innovators Showcase Deployment-Ready AI Healthcare Solutions

Taiwan Excellence Pavilion debuts at HIMSS 2026 with practical AI, advanced digital care, and medical-grade computing built for real-world clinical impact LAS VEGAS–(BUSINESS WIRE)–#HIMMS26—HIMSS 2026 – Four pioneering Taiwanese companies—SURGLASSES, Imedtac, Wincomm, and Zinexts—put the spotlight on deployment-ready AI, digital care platforms, and medical-grade computing at the Taiwan Excellence Product Launch during HIMSS 2026, proving … [Read more…]